Development and Validation of a Bioanalytical Method for the Determination of Nimodipine Concentration in Plasma of Rats

Development and Validation of a Bioanalytical Method for the Determination of Nimodipine Concentration in Plasma of Rats

Nimodipine is a calcium channel blocker used for the prevention of cerebral vasospasm after subarachnoid hemorrhage, a type of strokes. Its unique ability to selectively dilate blood vessels in the brain makes it a crucial medication in neurology. Pharmaceutical analysis of nimodipine is important...

Full description

Saved in:

Bibliographic Details
Main Authors:	Samir Hasson Aziz Ramadhan, Khalid Kadhem Al-Kinani
Format:	Article
Language:	English
Published:	College of Pharmacy University of Baghdad 2025-03-01
Series:	Iraqi Journal of Pharmaceutical Sciences
Subjects:	bioanalytical method HPLC nimodipine pre-clinical pharmacokinetics validation
Online Access:	https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3055
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A green and robust LC–MS/MS bioanalytical method for sulopenem etzadroxil and probenecid: Optimization, validation, and pharmacokinetic application
by: Niloufer Tasnim Khazi, et al.
Published: (2025-12-01)

Validation of a sensitive bioanalytical method for metronidazole extraction from human plasma
by: Krishna Kumar Patel, et al.
Published: (2024-06-01)

An eco-friendly bioanalytical RP-HPLC method coupled with fluorescence detection for simultaneous estimation of felodipine and metoprolol
by: Mariam Wasim Beniamin, et al.
Published: (2025-05-01)

Bioanalytical method development for monoclonal antibodies: advances and challenges
by: Sudha Kallam, et al.
Published: (2025-03-01)

Development and validation of a high-performance liquid chromatography with tandem mass spectrometry method for quantification of tofacitinib in human plasma
by: E. S. Vetrova, et al.
Published: (2024-06-01)

Green bioanalytical method development and validation for estimation of Imeglimin hydrochloride using human plasma in pure form by LC–MS/MS
by: Chandni V. Chandarana, et al.
Published: (2025-06-01)

Magnesium as an adjunct to nimodipine in subarachnoid hemorrhage: a meta-analysis
by: Riva Satya Radiansyah, et al.
Published: (2025-02-01)

Efficacy of nimodipine in the treatment of subarachnoid hemorrhage: a meta-analysis
by: Jianqiang Liu, et al.
Published: (2022-07-01)

DETECTION SYSTEM OF A NEW-GENERATION BIOANALYTICAL DEVICE
by: E. V. Sysoev, et al.
Published: (2014-12-01)

Using ionic Liquids-Based Surfactant in formulating Nimodipine Polymeric Nanoparticles: A Promising Approach for Improved Performance
by: Asmaa M.Rashid, et al.
Published: (2025-03-01)

Nimodipine after aneurysmal subarachnoid hemorrhage: shortened treatment in an unselected patient cohort
by: Bryndís Baldvinsdóttir, et al.
Published: (2025-01-01)

Comment on shortened treatment with nimodipine in aneurysmal subarachnoid hemorrhage
by: Begoña Guardiola, et al.
Published: (2025-01-01)

Nimodipine protects Schwann and neuronal cells from cell death induced by cisplatin without affecting cancer cells
by: Sandra Leisz, et al.
Published: (2025-06-01)

Development and Validation of a Highly Sensitive LC–MS/MS Method for the Precise Quantification of Sitagliptin in Human Plasma and Its Application to Pharmacokinetic Study
by: Yuna Song, et al.
Published: (2025-07-01)

Effect of hydroxocobalamin on nimodipine-induced refractory vasoplegia in a patient with liver cirrhosis: a case report
by: Sally You
Published: (2025-06-01)

Repetitive intraarterial therapy with Milrinone and Nimodipine for severe refractory Vasospasm: own series and narrative literature review
by: Bernhard Wambacher, et al.
Published: (2025-01-01)

Quantification of Total and Unbound Selinexor Concentrations in Human Plasma by a Fully Validated Liquid Chromatography-Tandem Mass Spectrometry Method
by: Suhyun Lee, et al.
Published: (2025-07-01)

Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma
by: T. N. Komarov, et al.
Published: (2022-09-01)

Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study
by: N. S. Dubovik, et al.
Published: (2022-05-01)

Validation of Protein A chromatography: orthogonal method with size exclusion chromatography validation for mAb titer analysis
by: Sahinkaya Elif, et al.
Published: (2025-05-01)

A Potential Method for Enhanced Performance of Nimodipine by Spanlastic Nanovesicle with Tween 40 as Edge Activator
by: Hussein K. Alkufi, et al.
Published: (2025-06-01)

Optimization of therapeutic drug monitoring of vancomycin in newborns using “Dried Blood Spot” method
by: V. I. Petrov, et al.
Published: (2024-01-01)

Mechanism of nimodipine in treating neurodegenerative diseases: in silico target identification and molecular dynamic simulation
by: Shuang Zheng, et al.
Published: (2025-03-01)

Development and Validation of an HPLC-MS/MS Method for Quantification of Apixaban in Human Plasma
by: U. D. Filonova, et al.
Published: (2024-03-01)

Development and Validation of a Method for Determining Deferasirox in Human Blood Plasma by HPLC-UV
by: P. A. Karpova, et al.
Published: (2022-05-01)

Investigation of Metoprolol Concentrations in Plasma Using Automated Sample Preparation and LC-MS/MS Detection
by: Ionel-Bogdan Cioroiu, et al.
Published: (2024-10-01)

Development and Validation of Bioanalytical LC–MS/MS Method for Pharmacokinetic Assessment of Amoxicillin and Clavulanate in Human Plasma
by: Sangyoung Lee, et al.
Published: (2025-07-01)

Development and Validation of an HPLC-MS/MS Method for the Quantitative Determination of Etmaben in Human Blood Plasma
by: P. K. Karnakova, et al.
Published: (2024-03-01)

Bioanalytical assay for the quantification of rucaparib in rat plasma using UPLC-MS/MS: development, and validation for interaction with myricetin
by: Jingjing Nie, et al.
Published: (2025-05-01)

Simultaneous Determination of Candesartan and Hydrochlorothiazide in Human Plasma by HPLC-MS/MS
by: P. K. Karnakova, et al.
Published: (2021-11-01)

A bioanalytical method development and validation for quantification of glycopyrrolate and neostigmine in rat plasma by LC-MS and its application to pharmacokinetic study
by: P. Vasu Babu, et al.
Published: (2025-06-01)

Simultaneous Determination of Nirmatrelvir and Ritonavir in Human Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-05-01)

Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-09-01)

Determination of Nemonoxacin in Small Volumes of Rat Plasma and Bile by a Novel HPLC-Fluorescence Assay and Its Application to Disposition and Biliary Excretion Kinetics
by: Wu RL, et al.
Published: (2024-12-01)

Determination of Lappaconitin, Diterpene Alkaloide Obtained from Plants <i>Aconitum leucostomum</i>, and its Active Metabolite N-desacetyllappaconitin in Human Plasma and Blood
by: O. A. Archakova, et al.
Published: (2021-08-01)

Sensitive RP-HPLC method with fluorimetric detection for concurrent quantification of emtricitabine, Daclatasvir and Ledipasvir in human urine
by: Aya A. Youssef, et al.
Published: (2025-07-01)

Effect of Sample Preparation and Chromatographic Conditions on Background Signal
by: V. M. Kosman, et al.
Published: (2020-06-01)

Development and validation of the method of quantification of 5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide and its metabolites in laboratory animal plasma
by: I. I. Yaichkov, et al.
Published: (2024-09-01)

Validation of a HPLC-UV analytical and bioanalytical method for dexamethasone determination in nanoemulsions, porcine nasal mucosa, and mouse plasma and brain tissue
by: Luísa Degrandi Sehn, et al.
Published: (2025-07-01)

Simultaneous determination of lesinurad and co-administered drugs used in management of gout comorbidities to uncover potential pharmacokinetic interaction in rat plasma
by: Hadeel A. Khalil, et al.
Published: (2025-04-01)